Prognosis prediction of α-FAtE score for locoregional immunotherapy in hepatocellular carcinoma
The α-FAtE score is a superior predictor of prognosis in HCC patients receiving locoregional immunotherapy, offering a valuable tool for patient stratification and treatment planning.
Authors
- Jingwen Zou (ORCID: https://orcid.org/0000-0002-2052-1589)
- Jie Mei (ORCID: https://orcid.org/0000-0002-7111-9012)
- Xinhao Xiong
- Qiaoxuan Wang
- Rongping Guo
- Zehao Zheng (ORCID: https://orcid.org/0000-0003-1293-4874)
- Shaohua Li (ORCID: https://orcid.org/0000-0003-3101-3202)
- Renguo Guan (ORCID: https://orcid.org/0000-0002-9487-7369)
- Wei Wei (ORCID: https://orcid.org/0000-0001-5929-7409)
- Rongce Zhao
- Junyu Gan
Institutions
- Sun Yat-sen University (CN)
- Guangdong Academy of Medical Sciences (CN)
- Sun Yat-sen University Cancer Center (CN)
- Guangdong Provincial Center for Disease Control and Prevention (CN)
- Guangdong Provincial People's Hospital (CN)
- State Key Laboratory of Oncology in South China
- Southern Medical University (CN)
Publication Details
- Journal
- Frontiers in Immunology
- Published
- 2025-01-10
- DOI
- https://doi.org/10.3389/fimmu.2024.1496095
- Citations
- 2
- Primary Topic
- Hepatocellular Carcinoma Treatment and Prognosis
- Type
- article
- Field-Weighted Citation Impact
- 2.64
Funders
- National Natural Science Foundation of China
- Sun Yat-sen University